Golden Retriever Health Issues

Golden Retriever health issues form a landscape unlike almost any other breed. While beloved for its gentle temperament and trainability, the breed is unusually prone to cancer. The Morris Animal Foundation's Golden Retriever Lifetime Study is a long-term prospective project investigating cancer and other diseases in the breed. One United States study found cancer to be the cause of death in about 50% of Goldens, while several European studies found lower figures of 20-39%.

This article covers the major health conditions documented in Golden Retrievers, the genetic tests available, OFA screening statistics and practical guidance for prospective owners and breeders.

Summary Health Table

Condition	Estimated Prevalence	Screening / Genetic Test	OFA Database
Hip dysplasia	Common	OFA/PennHIP radiograph	Yes
Elbow dysplasia	Common	OFA elbow radiograph	Yes
Subvalvular aortic stenosis (SAS)	Breed predisposition; exact prevalence unclear	Echocardiography by cardiologist	Yes
Progressive retinal atrophy (prcd-PRA)	Carriers exist in the breed	DNA test (PRCD gene)	Yes
Ichthyosis	High carrier frequency reported	DNA test (PNPLA1 gene)	No
Cancer (all types)	Cancer is a leading cause of death (about 50% of deaths in one US study)	Surveillance / biopsy	No
Hypothyroidism	Elevated breed risk	Thyroid panel (T4, cTSH)	Yes
Pigmentary uveitis	Breed-associated condition of older dogs	Ophthalmic exam	Yes

Cancer: The Dominant Health Concern

No health issue in the Golden Retriever has attracted more research attention than cancer. One United States study found cancer to be the cause of death in approximately 50% of Goldens, while several European studies found a lower prevalence of 20-39%, which may reflect genetic divergence between the American and European populations. Goldens are especially prone to haemangiosarcoma and lymphoma, with an estimated lifetime risk of one in five for the former and one in eight for the latter.

Haemangiosarcoma arises from the cells lining blood vessels. In Goldens, it most commonly affects the spleen, right atrium of the heart and subcutaneous tissues. Splenic haemangiosarcoma typically presents acutely with sudden collapse due to internal bleeding, prior signs are usually absent.

Ultrasound examination of the spleen and heart is the most practical screening tool, though it cannot detect all early-stage tumours.

Lymphoma affects the lymphatic system and is among the more treatable canine cancers. Golden Retrievers develop both B-cell and T-cell lymphoma, with B-cell lymphoma carrying a better prognosis. The CHOP chemotherapy protocol (cyclophosphamide, doxorubicin, vincristine, prednisone) is the standard chemotherapy approach for canine lymphoma.

Osteosarcoma affects the long bones, most commonly the distal radius (front leg) or proximal humerus. It presents as progressive lameness with localised swelling, radiographs reveal characteristic lytic bone lesions. Standard of care is amputation followed by carboplatin chemotherapy. Limb-sparing surgery is an option at specialist centres.

Routine cancer surveillance in Goldens from age 6 onward is advisable. Biannual veterinary examinations, annual abdominal ultrasound and owner awareness of early warning signs (unexplained weight loss, lethargy, swollen lymph nodes, sudden collapse) form the practical screening protocol available to most owners.

Hip Dysplasia

Hip dysplasia (HD) is a common orthopaedic problem in Golden Retrievers. As with all large breeds, the condition results from abnormal development of the hip joint, leading to laxity, cartilage wear and progressive osteoarthritis.

Clinical signs follow the same two patterns seen in other large breeds: early-onset stiffness and exercise intolerance in growing dogs (6-12 months), or insidious onset of hindlimb stiffness in middle-aged to older dogs.

The Golden Retriever Club of America (GRCA) recommends OFA hip evaluation at 24 months or PennHIP from 16 weeks of age for all breeding stock. The GRCA CHIC program (Canine Health Information Center) requires a passing OFA hip score for a dog to receive a CHIC number, which indicates health testing has been completed and submitted to the OFA database.

Management mirrors that for other large breeds: weight control, low-impact exercise, physiotherapy, NSAIDs for pain management and surgery for severe cases. See also the general how to groom your dog at home guide for coat care advice relevant to Golden Retrievers.

Subvalvular Aortic Stenosis

Subvalvular aortic stenosis (SAS) is a congenital cardiac condition in which a ring of fibrous tissue forms just below the aortic valve, obstructing blood flow from the left ventricle into the aorta. Golden Retrievers are among the breeds with documented elevated predisposition. Severity ranges from trivial obstruction (audible as a soft murmur) to severe stenosis causing left ventricular hypertrophy, exercise intolerance, syncope and sudden death.

All Golden Retriever breeding stock should undergo cardiac auscultation by a board-certified veterinary cardiologist before each breeding. Dogs with a grade 2/6 or louder murmur should have echocardiographic evaluation. Dogs with confirmed moderate to severe SAS should not be bred.

Progressive Retinal Atrophy

As in Labrador Retrievers, the form of PRA most common in Goldens is prcd-PRA (progressive rod-cone degeneration), caused by a recessive mutation in the PRCD gene. Clinical presentation and management are identical: rod photoreceptor loss beginning in mid-life, progressing to complete blindness over months to years.

A DNA test is available. The GRCA CHIC program requires an annual eye examination, PRCD-PRA DNA testing is a recommended additional test. Breeders should not mate two carriers.

Ichthyosis

Ichthyosis is a skin condition that causes scaling and flaking of the skin and coat, giving affected dogs a rough, scurfy appearance. In Golden Retrievers it is caused by a recessive mutation in the PNPLA1 gene. Unlike many other breeds where ichthyosis is rare, carrier frequency in Goldens is reported to be high.

Mildly affected dogs (two copies of the mutation) show varying degrees of scaling. Severely affected dogs can have thickened, darkened skin, secondary infections and significant discomfort. A DNA test identifies clear, carrier and affected dogs. Breeders should avoid mating two carriers, one carrier mated to a clear dog will not produce affected offspring.

Management is symptomatic: medicated shampoos, moisturising leave-on sprays and omega-3 fatty acid supplementation to support skin barrier function. Severely affected dogs may require episodic veterinary dermatology care.

Pigmentary Uveitis

Golden Retriever pigmentary uveitis (GRPU) is a condition that appears to be unique to the breed. It causes chronic inflammation of the uveal tract (iris, ciliary body and choroid), leading to progressive opacification of the lens (cataract), elevated intraocular pressure (secondary glaucoma), and potentially blindness.

The condition is insidious: early signs such as small cysts on the iris (pigmented uveal cysts) are detectable by ophthalmic examination years before clinical uveitis develops. No causative mutation has yet been identified, though the condition appears to have a heritable component.

Annual ophthalmic examination by an ACVO diplomate is recommended for Golden Retrievers, beginning at 2 years of age. Dogs with pigmented uveal cysts on examination require more frequent monitoring. Treatment of established uveitis includes topical anti-inflammatory agents and, in cases with elevated pressure, anti-glaucoma medications. Lens extraction may be indicated for mature cataracts.

Hypothyroidism

Golden Retrievers are among the dog breeds with the highest reported incidence of acquired hypothyroidism, caused by lymphocytic thyroiditis (immune-mediated destruction of the thyroid gland) or idiopathic thyroid atrophy. Clinical signs include weight gain despite normal food intake, lethargy, cold intolerance, skin and coat changes (dry coat, bilateral symmetrical alopecia, hyperpigmentation), and reduced exercise tolerance.

Diagnosis is by measurement of total T4 (thyroxine) with confirmation by free T4 and canine thyroid-stimulating hormone (cTSH) when results are borderline. The OFA thyroid registry accepts annual thyroid testing results, the GRCA CHIC program includes thyroid evaluation as a recommended test. Treatment is daily oral levothyroxine (synthetic T4) with dose adjustments guided by 4-6 hour post-pill T4 monitoring.

Elbow Dysplasia

Elbow dysplasia is common in Golden Retrievers. As in Labradors, FMCP is the most common form. Management and screening recommendations are identical to those described for Labs: OFA elbow radiograph at 24 months, arthroscopic evaluation and treatment if indicated, and weight management.

Screening Recommendations for Breeding Stock

Test	Method	Minimum Age	Governing Body
Hip evaluation	OFA radiograph or PennHIP	24 months (OFA); 16 weeks (PennHIP)	OFA / PennHIP
Elbow evaluation	OFA radiograph	24 months	OFA
Cardiac auscultation	Exam by board-certified cardiologist	Before each breeding	OFA Cardiac
prcd-PRA DNA test	Cheek swab	Any age	OFA, Embark, GenSol
Ichthyosis DNA test	Cheek swab	Any age	Multiple labs
Annual eye examination	ACVO-diplomate ophthalmoscopy	Annual	OFA Eye Registry
Thyroid panel	Blood T4, cTSH	Annual (recommended)	OFA Thyroid

A GRCA CHIC number confirms that a dog's health testing has been completed and registered. Both parents should have CHIC numbers, or buyers should verify individual test results at ofa.org.

What to Ask a Breeder

Prospective Golden Retriever buyers should request documented proof of:

1. OFA or PennHIP hip evaluation showing Good or Excellent for both parents
2. OFA elbow Normal for both parents
3. Cardiac clearance by a board-certified cardiologist within the past 12 months for both parents
4. prcd-PRA DNA results (clear or carrier of known status, never two carriers mated)
5. Ichthyosis DNA results (at minimum one parent clear, to avoid affected offspring)
6. Annual eye examination clearance (OFA Eye Registry)
7. Thyroid evaluation (OFA Thyroid Registry or documented thyroid panel)

Longevity

A 2024 UK study found a median life expectancy of 13.2 years for the breed, compared with an average of 12.7 years for purebreds. The Golden Retriever Lifetime Study will provide more granular US longevity data as cohorts age.

Given the dominant role of cancer in Golden Retriever mortality, interventions that reduce cancer risk or support early detection have the greatest potential to extend healthy lifespan.

Maintaining lean body weight (which reduces systemic inflammation and insulin-like growth factor signalling associated with tumour development), avoiding unnecessary environmental chemical exposures, and attending biannual veterinary examinations from age 6 onward are the most evidence-supported practices currently available to owners.

For information on feeding practices that support healthy weight in Golden Retrievers and other large dogs, see the related articles on pet health care. For guidance on selecting a healthy dog or comparing Golden Retrievers to other breeds, see best dogs for families with kids and best dogs for first-time owners.

Patellar Luxation

Patellar luxation, in which the kneecap (patella) slips out of its normal groove on the femur, is documented at elevated rates in Golden Retrievers compared to the average dog population. Most cases in Goldens are Grade I or II (the patella can be manually luxated but returns spontaneously) and are clinically insignificant, producing only occasional skipping gait.

Grade III and IV luxation, in which the patella is permanently displaced, can cause progressive stifle arthritis and may require surgical correction (trochleoplasty, tibial tuberosity transposition). OFA patella evaluation is available and can be performed at any age from 12 months onward.

Dilated Cardiomyopathy

Dilated cardiomyopathy (DCM), marked by heart muscle weakness, enlarged chambers and reduced pumping efficiency, has garnered substantial focus in Golden Retrievers following the FDA's 2018 investigation of a potential connection between grain-free diets and DCM. The causal link continues to divide scientists, but Golden Retrievers appeared disproportionately in initial case reports.

Though existing data does not prove that grain-free diets cause DCM, veterinary cardiologists advise Golden Retrievers on grain-free diets have periodic cardiac auscultation, and dogs showing any exercise intolerance or respiratory signs get baseline echocardiography.

Management Summary for Golden Retriever Owners

Given the Golden Retriever's health profile, owners benefit from a proactive management approach:

• Annual veterinary examinations from puppyhood to 6 years , then increasing to twice-yearly examinations after age 6 to support early cancer detection
• Weight management throughout life. Maintain a body condition score of 4-5/9, obesity is both a direct health problem and an aggravating factor for joint disease and potentially cancer
• Joint monitoring. Note any changes in gait, reluctance to rise, or stiffness after exercise and discuss with a veterinarian promptly
• Skin and coat observation. Golden Retrievers with skin lesions, nodules, or unusual lumps should have fine-needle aspiration performed promptly rather than watchful waiting
• Eye examinations annually for early detection of pigmentary uveitis cysts
• Dental care. Goldens are prone to periodontal disease, which has systemic effects, see the dog dental care guide for guidance
• Genetic testing before breeding. Prcd-PRA and ichthyosis tests are available, affordable and the standard expectation from responsible breeders